Birmingham and Solihull Chooses Ascribe for Mental Health ePrescribing

AscribeMental health chiefs in the West Midlands have chosen an e-prescribing system from Ascribe after winning £500K from a government fund to improve patient safety. Ascribe, part of EMIS Group, will provide its Electronic Prescribing and Medicines Administration (ePMA) system to Birmingham and Solihull Mental Health NHS Foundation Trust. It follows an award to the Trust of £500K from the government’s ‘safer hospitals, safer wards’ initiative. The Trust says it chose Ascribe over Rio for the richer clinical functionality and scalability of its ePMA system.

"We are looking forward to working with Ascribe Ltd to support the roll-out of our electronic pharmacy and medicines management system" comments Nigel Barnes, Director of Pharmacy, Birmingham and Solihull Mental Health NHS Foundation Trust. "The introduction of ePMA will improve the accuracy and consistency of prescribing, improve the administration of medicines as well as general medicines management throughout the Trust, ultimately improving the quality of service we provide to patients through increasing patient safety and clinical effectiveness."

James Reed, Consultant Forensic Psychiatrist and Chief Clinical Information Officer, Birmingham and Solihull Mental Health NHS Foundation Trust commented: "This project will deliver clear benefits for patients in terms of safety and quality of practice. It will help all of our clinical staff to deliver the best care possible through reducing opportunities for errors and allowing easy access to information which until now has been tied up in paper records. This development forms an important step on our journey towards a paperless health record."

Paul Thomson, ePMA lead at Ascribe, commented "One of the detractors for Trusts to move to ePMA is that they are struggling to put together robust business cases. At Ascribe we help Trusts put their business case together with our effective benefits tool; based on our own experience with e-prescribing and published literature, the benefits tool allows trusts to put in the number of wards and number of beds as well as the drugs budget and other factors to create a personalised, compelling set of benefits and savings based upon their own activities."

About Ascribe
Ascribe delivers high quality clinical IT solutions and services to over 70% of the UK’s secondary healthcare providers, and serves customers in Australasia, Malaysia and Hong Kong. Core strengths include Pharmacy and ePrescribing, Electronic Patient Records (including Patient Administration Systems), Unscheduled Care solutions and Mental Health Client Management systems. In addition, Ascribe provides Consultancy expertise in Business Intelligence, Transformation and Integration.

Through integration and interoperability, Ascribe, as a member of EMIS Group, helps clinicians across multiple care settings, share vital information, facilitating better, more efficient healthcare and supporting longer and healthier lives.

Ascribe is a Microsoft Gold Partner and was awarded Health Partner of the Year in 2012 and Microsoft Business Intelligence Finalist in 2014.

About EMIS Group
EMIS Group is the UK leader in connected healthcare software and services. Its solutions are widely used across every major UK healthcare setting from primary and community care, to high street pharmacies, secondary care and specialist services. Through integration and interoperability, EMIS Group helps clinicians share vital information, facilitating better, more efficient healthcare and supporting longer and healthier lives.

EMIS Group serves:

  • Primary & Community Care, under the EMIS brand, the UK leader in clinical IT systems for GPs and commissioners. EMIS Group products, including the flagship EMIS Web, hold over 40 million patient records and are used by nearly 6,000 healthcare organisations, including community-based teams. EMIS's patient.co.uk website is the UK's leading independent provider of patient-centric medical and well-being information and related transactional services.
  • Community Pharmacy, under the Rx Systems brand, the UK’s single most used integrated community pharmacy and retail system.
  • Secondary & Specialist Care, under the Ascribe and Digital Healthcare brands. Ascribe is a leading software provider to 70% of the UK's NHS Acute Trusts and Boards, focused primarily on Hospital Pharmacy, A&E (holding over 30 million patient records), Mental Health and Patient Administration Systems. Digital Healthcare is England’s leading provider of diabetic eye screening and other ophthalmology-related solutions.

© Ascribe 2014. Ascribe is a registered trademark. All other brands and product names and trademarks are the registered property of their respective companies.

About Birmingham and Solihull Mental Health NHS Foundation Trust
Our Trust provides a comprehensive mental healthcare service for residents of Birmingham and Solihull, and to communities in the West Midlands and beyond. The Trust operates out of more than 50 sites, serves a culturally and socially diverse population of 1.2 million spread over 172 square miles, has an income of more than £230million and a dedicated workforce of more than 4,000 staff, making it one of the largest and most complex mental health foundation trusts in the country.

The Care Quality Commission rated the Trust ‘Good’ following its first full inspection of our services in May 2014 under its new inspection approach for mental health services.

Most Popular Now

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...

Does AI Improve Doctors' Diagnoses?

With hospitals already deploying artificial intelligence to improve patient care, a new study has found that using Chat GPT Plus does not significantly improve the accuracy of doctors' diagnoses when...

AI Analysis of PET/CT Images can Predict…

Dr. Watanabe and his teams from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI) can predict the occurrence of interstitial lung disease, known as a serious...